Articles

Bayer said it will explore access options for patients with follicular lymphoma currently receiving Aliqopa who have experienced a favorable response to treatment.

Bayer Withdraws US Indication for Aliqopa in Treatment of Follicular Lymphoma 

JMA Journal report describes how businesses in this Asian-Pacific nation are employing various strategies to reduce GHG emissions. 

Japan Shifts Toward Environmentally Friendly Pharma Practices 

A demand-driven methodology for data standardization across multiple streams of acquisition could improve the sharing of real-world data worldwide.

Improved Data Sharing, Collaborative Learning Could Enhance Real-World Data Analysis

Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.

Pacira BioSciences Announces FDA Approval of Expanded Indications for Exparel

The Flowflex COVID-19 Antigen Home Test is the first over-the-counter rapid antigen test for SARS-CoV-2 to gain FDA 510(k) marketing clearance by the FDA.

FDA Grants 510(k) Marketing Clearance to Flowflex COVID-19 Antigen Home Test

New E2E workflow orchestration service is expected to simplify the processes of health systems and retail pharmacies while also reducing the risk of recalled items reaching patients.

TraceLink Introduces Digital Recalls Solution 

Fruquintinib (Fruzaqla) is a significant new therapy for patients who have had limited options to treat metastatic colorectal cancer.

Novel Chemotherapy-Free Fruzaqla Gets FDA Approval for Metastatic Colorectal Cancer 

Tirzepatide (Zepbound; Eli Lilly and Company) will hit the US market by the end of 2023 with a list price of $1,059.87.

Lilly's Tirzepatide Gets FDA Approval for Chronic Weight Management 

Rexulti was found to be a well-tolerated treatment for the debilitating symptoms of agitation associated with dementia due to Alzheimer’s disease.

Rexulti Shows Efficacy Treating Agitation Associated With Dementia Due to Alzheimer Disease 

Ayala Pharmaceuticals’ AL102 is a gamma secretase inhibitor being studied to treat patients with desmoid tumors.

News